《“d6 - 25 - 羟基维生素D3的液相色谱 - 串联质谱测定中的正干扰观察”勘误》[临床质谱学 3 (2017) 22 - 24]
Corrigendum to "Observation of a positive interference in LC-MS/MS measurement of d6-25-OH-vitamin D3" [Clin. Mass Spectrom. 3 (2017) 22-24].
作者信息
Fortuna Danielle, Korn Warren R, Brune Matthew J, He Xiang, Wang Alexandre Y, Hevko John M, Stickle Douglas F
机构信息
Jefferson University Hospital, Philadelphia, PA, USA.
AB Sciex LLC, Redwood City, CA, USA.
出版信息
J Mass Spectrom Adv Clin Lab. 2022 Sep 9;26:20. doi: 10.1016/j.jmsacl.2022.09.002. eCollection 2022 Nov.
Abstract
[This corrects the article DOI: 10.1016/j.clinms.2017.06.001.].
摘要
[本文更正了文章的数字对象标识符：10.1016/j.clinms.2017.06.001。]
相似文献
1
Corrigendum to "Observation of a positive interference in LC-MS/MS measurement of d6-25-OH-vitamin D3" [Clin. Mass Spectrom. 3 (2017) 22-24].
J Mass Spectrom Adv Clin Lab. 2022 Sep 9;26:20. doi: 10.1016/j.jmsacl.2022.09.002. eCollection 2022 Nov.
2
Corrigendum to "Migration from RIA to LC-MS/MS for aldosterone determination: Implications for clinical practice and determination of plasma and urine reference range intervals in a cohort of healthy Belgian subjects" [Clin. Mass Spectrom. 9 (2018) 7-17].
J Mass Spectrom Adv Clin Lab. 2022 Oct 26;26:47. doi: 10.1016/j.jmsacl.2022.10.001. eCollection 2022 Nov.
3
Corrigendum to "Instability of 7-aminoclonazepam in frozen storage conditions" [Clin. Mass Spectrom. 9 (2018) 23-24].
J Mass Spectrom Adv Clin Lab. 2022 Sep 24;26:34. doi: 10.1016/j.jmsacl.2022.09.006. eCollection 2022 Nov.
4
Corrigendum to "Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs" [Clin. Mass Spectrom. 14(Part A) (2019) 34-45].
J Mass Spectrom Adv Clin Lab. 2022 Aug 13;25:72. doi: 10.1016/j.jmsacl.2022.08.001. eCollection 2022 Aug.
5
Corrigendum to "Analytical validation of protein biomarkers for risk of spontaneous preterm birth" [Clin. Mass Spectrom. 3 (2017) 25-38].
J Mass Spectrom Adv Clin Lab. 2022 Aug 9;25:71. doi: 10.1016/j.jmsacl.2022.07.007. eCollection 2022 Aug.
6
Corrigendum to "Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer's disease" [Clin. Mass Spectrom. 14 (Part B) (2019) 74-82].
J Mass Spectrom Adv Clin Lab. 2022 Sep 28;26:35. doi: 10.1016/j.jmsacl.2022.08.002. eCollection 2022 Nov.
7
Corrigendum to "Manipulating trypsin digestion conditions to accelerate proteolysis and simplify digestion workflows in development of protein mass spectrometric assays for the clinical laboratory" [Clin. Mass Spectrom. 6C (2018) 1-12].
Clin Mass Spectrom. 2018 Aug 30;10:33-34. doi: 10.1016/j.clinms.2018.08.005. eCollection 2018 Dec.
8
Corrigendum to "Development and validation of a multiplexed LC-MS/MS ketone body assay for clinical diagnostics" [J. Mass Spectrom. Adv. Clin. Lab 31 (2024) 49-58].
J Mass Spectrom Adv Clin Lab. 2024 Jul 17;33:21. doi: 10.1016/j.jmsacl.2024.07.001. eCollection 2024 Aug.
9
Observation of a positive interference in LC-MS/MS measurement of d-25-OH-vitamin D3.
Clin Mass Spectrom. 2017 Jun 3;3:22-24. doi: 10.1016/j.clinms.2017.06.001. eCollection 2017 Jan.
10
Development and validation of the simultaneous measurement of four vitamin D metabolites in serum by LC-MS/MS for clinical laboratory applications.
Anal Bioanal Chem. 2016 Nov;408(27):7617-7627. doi: 10.1007/s00216-016-9821-4. Epub 2016 Aug 15.
Zotero 插件